• Contact Info

Dr Doug Fairlie Principal Research Fellow, Biochemistry

Doug Fairlie obtained his PhD in Biochemistry from Monash University in 1994. After a postdoctoral stint in the US at the State University New York, Buffalo, he returned to Australia in 1996 to work at the Centre for Immunology, St Vincent's Hospital, Sydney where he was the lead protein chemist on projects involving TGF-beta-related cytokines and a novel intracellular ion channel.

In 2001, Doug joined the Cancer and Haematology Division at the Walter and Eliza Hall Institute to continue work on cytokines including IL-6 family members. In 2003, he moved to the Structural Biology Division at WEHI where he commenced working on cell death and survival mechanisms and was promoted to a laboratory head in 2010.

In 2015, Doug took up a joint appointment between the Department of Biochemistry and Genetics and The Olivia Newton-John Cancer Research Institute. He is focused on understanding how cell death is regulated, especially in the context of cancer cells, and is working towards developing new drugs targeting the apoptosis pathways in these and other tumours. His work is funded by grants from the NHMRC, Cancer Council of Victoria and Worldwide Cancer Research, UK.


Research Areas research areas